Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 7 Carcinoma, Hepatocellular 6 Liver Neoplasms 5 Pancreatic Neoplasms 4 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Diseases 1 Laryngeal Neoplasms 1 Hilus Pulmonary Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Renal Cell 1 Bile Duct Neoplasms 1

Interventions

Stents 2 motexafin lutetium 1 Yoga 1 Radiofrequency Ablation 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Electroporation 1 Cisplatin 1 Cholecystectomy 1 Cholangiopancreatography, Endoscopic Retrograde 1 Bariatric Surgery 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Gallbladder Neoplasms × Electroporation × Clear all

NCT02430662 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡